David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
PUT
Salesforce
CRM
$171B
| $13.5M | 0.02% |
98,800
-108,600
| -52% | -$13.9M |
|
|
SINA
902
DELISTED
Sina Corp
SINA
| $13.4M | 0.02% |
158,103
-169,996
| -52% | -$15.8M |
|
903
CALL
Norfolk Southern
NSC
$79.3B
| $13.3M | 0.02% |
88,400
+12,100
| +16% | +$1.77M |
|
904
CALL
Arista Networks
ANET
$237B
| $13.3M | 0.02% |
827,200
| – | – |
|
|
HIBB
905
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $13.3M | 0.02% |
578,882
-32,706
| -5% | -$852K |
|
906
W&T Offshore
WTI
$574M
| $13.2M | 0.02% |
1,849,440
+1,428,705
| +340% | +$9.24M |
|
907
Bank of N.T. Butterfield & Son
NTB
$2.3B
| $13.2M | 0.02% |
287,632
+56,961
| +25% | +$2.69M |
|
908
CALL
Elevance Health
ELV
$87.3B
| $13.1M | 0.02% |
55,000
+9,600
| +21% | +$2.22M |
|
909
Semtech
SMTC
$11.3B
| $13.1M | 0.02% |
277,582
-136,894
| -33% | -$6.14M |
|
|
IRBT
910
DELISTED
iRobot
IRBT
| $13M | 0.02% |
+172,161
| New | +$11.4M |
|
911
Zurn Elkay Water Solutions
ZWS
$8.1B
| $13M | 0.02% |
931,489
+101,475
| +12% | +$1.43M |
|
912
CALL
Boston Beer
SAM
$1.95B
| $13M | 0.02% |
+43,400
| New | +$10.6M |
|
913
Brady Corp
BRC
$4.45B
| $13M | 0.02% |
336,984
+44,711
| +15% | +$1.72M |
|
914
PUT
Eli Lilly
LLY
$1.11T
| $12.9M | 0.02% |
151,400
-6,500
| -4% | -$534K |
|
|
HZNP
915
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12.9M | 0.02% |
780,117
+287,032
| +58% | +$4.38M |
|
|
BRS
916
DELISTED
Bristow Group, Inc.
BRS
| $12.9M | 0.02% |
913,493
+262,235
| +40% | +$3.92M |
|
917
Entegris
ENTG
$21.1B
| $12.9M | 0.02% |
379,999
-67,290
| -15% | -$2.38M |
|
918
State Street SPDR S&P Retail ETF
XRT
$329M
| $12.9M | 0.02% |
265,000
+105,700
| +66% | +$4.93M |
|
919
Louisiana-Pacific
LPX
$5.08B
| $12.9M | 0.02% |
472,154
-167,626
| -26% | -$4.83M |
|
920
PUT
Cboe Global Markets
CBOE
$32.2B
| $12.8M | 0.02% |
123,300
-89,100
| -42% | -$9.41M |
|
921
Nike
NKE
$60.5B
| $12.8M | 0.02% |
160,938
+93,940
| +140% | +$6.62M |
|
|
FITB
922
Fifth Third Bancorp
FITB
$49.8B
| $12.8M | 0.02% |
446,534
-528,943
| -54% | -$16.8M |
|
923
CALL
Lam Research
LRCX
$388B
| $12.8M | 0.02% |
740,000
+300,000
| +68% | +$5.78M |
|
924
Liberty Latin America Class C
LILAK
$1.64B
| $12.8M | 0.02% |
769,839
-416,590
| -35% | -$7.27M |
|
925
AerCap
AER
$23.2B
| $12.8M | 0.02% |
235,698
-134,797
| -36% | -$7.26M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.